Literature DB >> 16177193

Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds.

Pernilla C Karlsson1, Ulrika Huss, Andrew Jenner, Barry Halliwell, Lars Bohlin, Joseph J Rafter.   

Abstract

The inducible enzyme cyclooxygenase-2 (COX-2) plays a major role in the regulation of inflammation and possibly in the development of colon cancer. The aim of the present study was to screen for COX-2 inhibitors in samples of fecal water (the aqueous phase of feces) and investigate whether phenolic compounds are responsible for any observed effects on COX-2. Volunteers (n = 20) were recruited and asked to supply a 24-h stool sample. Fecal water samples were prepared and analyzed by GC-MS for their content of phenolic compounds. These samples were also evaluated for their effects on COX-2 protein levels (Western blot) and prostaglandin (PG)E2 production in tumor necrosis-alpha-stimulated HT-29 cells and pure enzymatic activity in a COX-2-catalyzed prostaglandin biosynthesis in vitro assay. The major phenolic compounds identified were phenylpropionic acid, phenylacetic acid, cinnamic acid, and benzoic acid derivatives. Of 13 fecal water samples analyzed, 12 significantly decreased PGE2 production (range 5.4-39.7% inhibition, P-value < 0.05) compared with control cells and 13 of 14 samples analyzed decreased COX-2 protein levels in HT-29 cells (19-63% inhibition). Of the 20 fecal water samples, 2 also weakly inhibited enzymatic activity of purified COX-2 (22-24% inhibition). Three compounds identified in fecal water, 3-phenylpropionic acid, 3-hydroxyphenylacetic acid, and 3-(4-hydroxyphenyl)-propionic acid, decreased the protein level at 250 micromol/L (15-62% inhibition). This study shows for the first time that human fecal water contains components that can affect both the COX-2 protein level and enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177193     DOI: 10.1093/jn/135.10.2343

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  15 in total

1.  Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.

Authors:  Samyeol Seo; Sunghong Lee; Yongpyo Hong; Yonggyun Kim
Journal:  Appl Environ Microbiol       Date:  2012-03-23       Impact factor: 4.792

2.  Metabolomics reveals metabolic biomarkers of Crohn's disease.

Authors:  Janet Jansson; Ben Willing; Marianna Lucio; Ages Fekete; Johan Dicksved; Jonas Halfvarson; Curt Tysk; Philippe Schmitt-Kopplin
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

3.  Relationship between Fecal Content of Fatty Acids and Cyclooxygenase mRNA Expression and Fatty Acid Composition in Duodenal Biopsies, Serum Lipoproteins, and Dietary Fat in Colectomized Familial Adenomatous Polyposis Patients.

Authors:  K Almendingen; A T Høstmark; L N Larsen; O Fausa; J Bratlie; L Aabakken
Journal:  J Nutr Metab       Date:  2010-10-28

Review 4.  Approaches that ascertain the role of dietary compounds in colonic cancer cells.

Authors:  Michael Bordonaro; Koen Venema; Adeline K Putri; Darina Lazarova
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

5.  Profiles of Microbial Fatty Acids in the Human Metabolome are Disease-Specific.

Authors:  Zhanna A Ktsoyan; Natalia V Beloborodova; Anahit M Sedrakyan; George A Osipov; Zaruhi A Khachatryan; Denise Kelly; Gayane P Manukyan; Karine A Arakelova; Alvard I Hovhannisyan; Andrey Y Olenin; Arsen A Arakelyan; Karine A Ghazaryan; Rustam I Aminov
Journal:  Front Microbiol       Date:  2011-01-20       Impact factor: 5.640

6.  An inserted α/β subdomain shapes the catalytic pocket of Lactobacillus johnsonii cinnamoyl esterase.

Authors:  Kin-Kwan Lai; Peter J Stogios; Clara Vu; Xiaohui Xu; Hong Cui; Sara Molloy; Alexei Savchenko; Alexander Yakunin; Claudio F Gonzalez
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

7.  Pilot dietary intervention with heat-stabilized rice bran modulates stool microbiota and metabolites in healthy adults.

Authors:  Amy M Sheflin; Erica C Borresen; Melissa J Wdowik; Sangeeta Rao; Regina J Brown; Adam L Heuberger; Corey D Broeckling; Tiffany L Weir; Elizabeth P Ryan
Journal:  Nutrients       Date:  2015-02-16       Impact factor: 5.717

Review 8.  Towards microbial fermentation metabolites as markers for health benefits of prebiotics.

Authors:  Kristin A Verbeke; Alan R Boobis; Alessandro Chiodini; Christine A Edwards; Anne Franck; Michiel Kleerebezem; Arjen Nauta; Jeroen Raes; Eric A F van Tol; Kieran M Tuohy
Journal:  Nutr Res Rev       Date:  2015-06       Impact factor: 7.800

9.  Effect of phenolic acids of microbial origin on production of reactive oxygen species in mitochondria and neutrophils.

Authors:  Natalia Beloborodova; Iskander Bairamov; Andrei Olenin; Victoria Shubina; Vera Teplova; Nadezhda Fedotcheva
Journal:  J Biomed Sci       Date:  2012-10-12       Impact factor: 8.410

Review 10.  Caffeoylquinic acids: chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity.

Authors:  Armando Alcázar Magaña; Naofumi Kamimura; Amala Soumyanath; Jan F Stevens; Claudia S Maier
Journal:  Plant J       Date:  2021-07-23       Impact factor: 7.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.